Literature DB >> 12874304

Expression of cytokine and chemokine genes by human middle ear epithelial cells induced by influenza A virus and Streptococcus pneumoniae opacity variants.

H H Tong1, J P Long, P A Shannon, T F DeMaria.   

Abstract

Real-time PCR and enzyme-linked immunosorbent assay were used to evaluate the ability of influenza A virus and Streptococcus pneumoniae opacity variants, either alone or in combination, to induce cytokine and chemokine genes in primary cultures of human middle ear epithelial (HMEE) cells. Following treatment with influenza A virus, the induction of gene expression, which occurred in a dose- and time-dependent manner, was strong for macrophage inflammatory protein 1 alpha (MIP-1 alpha) and MIP-1 beta; moderate for tumor necrosis factor alpha (TNF-alpha), interleukin-6 (IL-6), and IL-8; and weak for IL-1 beta and monocyte chemotactic peptide 1 (MCP-1). Except for TNF-alpha, all the gene products were detected in the cell culture supernatants. In contrast, infection of HMEE cells with S. pneumoniae alone induced low levels of mRNA expression of MIP-1 alpha and MIP-1 beta and did not significantly induce the transcription of the other cytokines and chemokines examined. However, both S. pneumoniae opacity variants increased mRNA expression of MIP-1 alpha, MIP-1 beta, IL-6, and MCP-1 in HMEE cells activated by a prior influenza A virus infection compared to levels in cells treated with either agent alone. Up-regulation of IL-6, IL-8, and MCP-1 mRNA expression and production by the virus in combination with opaque S. pneumoniae was two- to threefold higher than that induced by the virus combined with the transparent S. pneumoniae variant. These data indicate that the activation of HMEE cells by influenza A virus enhances the induction of cytokine and chemokine gene transcripts by S. pneumoniae and that this effect appears to be most pronounced when S. pneumoniae is in the opaque phase.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12874304      PMCID: PMC166016          DOI: 10.1128/IAI.71.8.4289-4296.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  43 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Influenza A and sendai viruses induce differential chemokine gene expression and transcription factor activation in human macrophages.

Authors:  S Matikainen; J Pirhonen; M Miettinen; A Lehtonen; C Govenius-Vintola; T Sareneva; I Julkunen
Journal:  Virology       Date:  2000-10-10       Impact factor: 3.616

Review 3.  Molecular pathogenesis of influenza A virus infection and virus-induced regulation of cytokine gene expression.

Authors:  I Julkunen; T Sareneva; J Pirhonen; T Ronni; K Melén; S Matikainen
Journal:  Cytokine Growth Factor Rev       Date:  2001 Jun-Sep       Impact factor: 7.638

Review 4.  Macrophage inflammatory protein-1.

Authors:  Patricia Menten; Anja Wuyts; Jo Van Damme
Journal:  Cytokine Growth Factor Rev       Date:  2002-12       Impact factor: 7.638

5.  Expression of cytokine genes during pneumococcal and nontypeable Haemophilus influenzae acute otitis media in the rat.

Authors:  A Melhus; A F Ryan
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

6.  Effects of influenza A virus on lectin-binding patterns in murine nasopharyngeal mucosa and on bacterial colonization.

Authors:  T Hirano; Y Kurono; I Ichimiya; M Suzuki; G Mogi
Journal:  Otolaryngol Head Neck Surg       Date:  1999-11       Impact factor: 3.497

7.  Effect of adenovirus type 1 and influenza A virus on Streptococcus pneumoniae nasopharyngeal colonization and otitis media in the chinchilla.

Authors:  H H Tong; L M Fisher; G M Kosunick; T F DeMaria
Journal:  Ann Otol Rhinol Laryngol       Date:  2000-11       Impact factor: 1.547

8.  Expression of cytokine and chemokine genes by human middle ear epithelial cells induced by formalin-killed Haemophilus influenzae or its lipooligosaccharide htrB and rfaD mutants.

Authors:  H H Tong; Y Chen; M James; J Van Deusen; D B Welling; T F DeMaria
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

9.  Experimental otitis media after nasal inoculation of Streptococcus pneumoniae and influenza A virus in chinchillas.

Authors:  G S Giebink; I K Berzins; S C Marker; G Schiffman
Journal:  Infect Immun       Date:  1980-11       Impact factor: 3.441

10.  Influenza A virus-induced polymorphonuclear leukocyte dysfunction in the pathogenesis of experimental pneumococcal otitis media.

Authors:  J S Abramson; G S Giebink; P G Quie
Journal:  Infect Immun       Date:  1982-04       Impact factor: 3.441

View more
  9 in total

1.  An Atlas of Genetic Variation Linking Pathogen-Induced Cellular Traits to Human Disease.

Authors:  Liuyang Wang; Kelly J Pittman; Jeffrey R Barker; Raul E Salinas; Ian B Stanaway; Graham D Williams; Robert J Carroll; Tom Balmat; Andy Ingham; Anusha M Gopalakrishnan; Kyle D Gibbs; Alejandro L Antonia; Joseph Heitman; Soo Chan Lee; Gail P Jarvik; Joshua C Denny; Stacy M Horner; Mark R DeLong; Raphael H Valdivia; David R Crosslin; Dennis C Ko
Journal:  Cell Host Microbe       Date:  2018-08-08       Impact factor: 21.023

2.  Complement activation in pediatric patients with recurrent acute otitis media.

Authors:  Yujuan He; Melissa A Scholes; Gregory J Wiet; Qian Li; Caitlin Clancy; Hua Hua Tong
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2013-03-26       Impact factor: 1.675

3.  Influenza-induced inflammation drives pneumococcal otitis media.

Authors:  Kirsty R Short; Patrick C Reading; Lorena E Brown; John Pedersen; Brad Gilbertson; Emma R Job; Kathryn M Edenborough; Marrit N Habets; Aldert Zomer; Peter W M Hermans; Dimitri A Diavatopoulos; Odilia L Wijburg
Journal:  Infect Immun       Date:  2013-01-14       Impact factor: 3.441

4.  Interaction of pneumococcal phase variation and middle ear pressure/gas composition: an in vitro model of simulated otitis media.

Authors:  Ha-Sheng Li-Korotky; Juliane M Banks; Chia-Yee Lo; Fan-Rui Zeng; Donna B Stolz; J Douglas Swarts; William J Doyle
Journal:  Microb Pathog       Date:  2008-06-03       Impact factor: 3.738

5.  Capsular sialic acid of Streptococcus suis serotype 2 binds to swine influenza virus and enhances bacterial interactions with virus-infected tracheal epithelial cells.

Authors:  Yingchao Wang; Carl A Gagnon; Christian Savard; Nedzad Music; Mariela Srednik; Mariela Segura; Claude Lachance; Christian Bellehumeur; Marcelo Gottschalk
Journal:  Infect Immun       Date:  2013-09-30       Impact factor: 3.441

6.  Immunogenicity and protection efficacy of replication-deficient influenza A viruses with altered NS1 genes.

Authors:  Boris Ferko; Jana Stasakova; Julia Romanova; Christian Kittel; Sabine Sereinig; Hermann Katinger; Andrej Egorov
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

7.  HIF-VEGF pathways are critical for chronic otitis media in Junbo and Jeff mouse mutants.

Authors:  Michael T Cheeseman; Hayley E Tyrer; Debbie Williams; Tertius A Hough; Paras Pathak; Maria R Romero; Helen Hilton; Sulzhan Bali; Andrew Parker; Lucie Vizor; Tom Purnell; Kate Vowell; Sara Wells; Mahmood F Bhutta; Paul K Potter; Steve D M Brown
Journal:  PLoS Genet       Date:  2011-10-20       Impact factor: 5.917

Review 8.  Respiratory viral infections drive chemokine expression and exacerbate the asthmatic response.

Authors:  Matthew Schaller; Cory M Hogaboam; Nicholas Lukacs; Steven L Kunkel
Journal:  J Allergy Clin Immunol       Date:  2006-08       Impact factor: 10.793

9.  Live attenuated influenza vaccine enhances colonization of Streptococcus pneumoniae and Staphylococcus aureus in mice.

Authors:  Michael J Mina; Jonathan A McCullers; Keith P Klugman
Journal:  MBio       Date:  2014-02-18       Impact factor: 7.867

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.